Pages that link to "Q57214741"
Jump to navigation
Jump to search
The following pages link to SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability (Q57214741):
Displaying 11 items.
- Simple Pseudo-dipeptides with a P2' Glutamate: A NOVEL INHIBITOR FAMILY OF MATRIX METALLOPROTEASES AND OTHER METZINCINS (Q27681108) (← links)
- Regulation and involvement of matrix metalloproteinases in vascular diseases (Q33773304) (← links)
- Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro. (Q34631606) (← links)
- New strategies for targeting matrix metalloproteinases (Q35544060) (← links)
- The history of matrix metalloproteinases: milestones, myths, and misperceptions (Q36312509) (← links)
- Matrix metalloproteinase inhibitors: a patent review (2011 - 2013). (Q38237471) (← links)
- Clinical implications of compounds designed to inhibit ECM-modifying metalloproteinases. (Q38430546) (← links)
- Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases. (Q38432023) (← links)
- Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds. (Q38461606) (← links)
- Matrix metalloproteinases: new directions toward inhibition in the fight against cancers (Q38748426) (← links)
- Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents (Q39443765) (← links)